Quinine Sulphate proposed by us is an antimalarial drug prescribed or used only for treating uncomplicated Plasmodium falciparum malaria. It has been exhibited to be effective in geographical regions where resistance against chloroquine has been acknowledged. Precisely formulated with approved molecular formula of C40H50N4O8S, it is featured with melting point of 233-235 C, molecular weight of 782.96 g/mol, pH (1%soln/water) of 5.7-6.6, and purity of 99.0%. Quinine Sulphate is soluble in about 120-mlalcohol, and in about 500ml water. Also, it is slightly soluble ether or inchloroform.
Developed and Managed by Infocom Network Private Limited.